<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>INTERNATIONAL COALITION FOR DRUG AWARENESS &#187; Company Memo</title>
	<atom:link href="http://www.drugawareness.org/tag/company-memo/feed" rel="self" type="application/rss+xml" />
	<link>http://www.drugawareness.org</link>
	<description></description>
	<lastBuildDate>Mon, 20 May 2013 23:00:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5</generator>
		<item>
		<title>PAXIL TRIAL: Glaxo Executive’s Memo Suggested Burying Drug Studies (Update4)</title>
		<link>http://www.drugawareness.org/recentcasesblog/paxil-trial-glaxo-executive%e2%80%99s-memo-sugg</link>
		<comments>http://www.drugawareness.org/recentcasesblog/paxil-trial-glaxo-executive%e2%80%99s-memo-sugg#comments</comments>
		<pubDate>Tue, 15 Sep 2009 21:02:03 +0000</pubDate>
		<dc:creator>Ann Blake-Tracy</dc:creator>
				<category><![CDATA[Recent Cases Blog]]></category>
		<category><![CDATA[Animal Studies]]></category>
		<category><![CDATA[Ann Blake Tracy]]></category>
		<category><![CDATA[Antidepressant Drug]]></category>
		<category><![CDATA[Birth Defects]]></category>
		<category><![CDATA[Church Congregation]]></category>
		<category><![CDATA[Company Memo]]></category>
		<category><![CDATA[Cronin]]></category>
		<category><![CDATA[Drug Paxil]]></category>
		<category><![CDATA[Glaxo]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[Glaxosmithkline Plc]]></category>
		<category><![CDATA[Heart Defects]]></category>
		<category><![CDATA[Heart Surgery]]></category>
		<category><![CDATA[Jef]]></category>
		<category><![CDATA[Margaret Cronin Fisk]]></category>
		<category><![CDATA[Opening Statements]]></category>
		<category><![CDATA[Paxil]]></category>
		<category><![CDATA[Philadelphia Trial]]></category>
		<category><![CDATA[Prozac]]></category>
		<category><![CDATA[Rossello]]></category>

		<guid isPermaLink="false">http://www.drugawareness.org/recentcases/paxil-trial-glaxo-executive%e2%80%99s-memo-sugg</guid>
		<description><![CDATA[Sept. 15 (Bloomberg) -- An executive of GlaxoSmithKline Plc, the world’s second-biggest drugmaker, talked about burying negative studies linking its antidepressant drug Paxil to birth defects, according to a company memo introduced at a trial.

“If neg, results can bury,” Glaxo executive Bonnie Rossello wrote in a 1997 memo on what the company would do if forced to conduct animal studies on the drug. The memo was read during opening statements in the trial of a lawsuit brought by the family of a child born with heart defects.]]></description>
		<wfw:commentRss>http://www.drugawareness.org/recentcasesblog/paxil-trial-glaxo-executive%e2%80%99s-memo-sugg/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
